Oxymatrine Induces Liver Injury through JNK Signalling Pathway Mediated by TNF-α In Vivo

Hong Lu1, Li Zhang2, Li-Li Gu1

  • 1College of Pharmaceutical Science, Zhejiang Chinese Medical University, Hangzhou, China.

Insights

Oxymatrine (OMT) may cause liver damage in mice, indicated by elevated liver enzymes and histological injury. This hepatotoxicity is linked to the tumor necrosis factor-alpha (TNF-α) pathway activation and stress-activated protein kinase/c-jun N-terminal protein kinases (SAPK/JNK) signaling.

Area of Science:

  • Pharmacology
  • Toxicology
  • Hepatology

Background:

  • Oxymatrine (OMT) is a component of traditional Chinese medicine used for chronic viral hepatitis.
  • Its potential for inducing liver toxicity requires investigation.

Purpose of the Study:

  • To determine if Oxymatrine (OMT) induces hepatotoxicity in mice.
  • To explore the preliminary mechanisms underlying OMT-induced liver damage.

Main Methods:

  • Male ICR mice were administered OMT daily for 7 days at doses of 40, 160, and 320 mg/kg.
  • Liver index, serum enzymes (ALT, AST, ALP), oxidative stress markers (MDA), inflammatory cytokines (TNF-α), and apoptosis-related proteins (caspase-9/-8/-3) were assessed.
  • Expression of TNFR1, TRADD, and p-SAPK/JNK was analyzed.

Main Results:

  • OMT treatment, particularly at 320 mg/kg, increased liver index and serum liver enzymes.
  • Histological analysis revealed augmented liver injury, elevated MDA and TNF-α levels.
  • Activation of caspase-9/-8/-3, upregulation of TNFR1, TRADD, and phosphorylation of SAPK/JNK were observed.

Conclusions:

  • Oxymatrine (OMT) at 320 mg/kg induces significant liver damage in mice.
  • OMT-induced hepatotoxicity is associated with TNF-α-mediated activation of the JNK signaling pathway.

Related Concept Videos